Table 1—

Baseline clinical and biochemical characteristics of the study groups

Control groupTriple therapy groupReference material
n (male/female)8 (4/4)8 (3/5)10 (8/2)
Age (years)61 ± 266 ± 456 ± 3
BMI (kg/m2)31.3 ± 1.932.1 ± 2.129.0 ± 0.5
HbA1c (%)9.1 ± 0.48.8 ± 0.95.4 ± 0.1
Fasting blood glucose (mmol/l)10.3 ± 1.19.3 ± 1.35.3 ± 0.1
Fasting serum insulin (pmol/l)104 ± 10104 ± 1430 ± 6
Fasting serum C-peptide (pmol/l)585 ± 103715 ± 152509 ± 50
Insulin dose per day (units/kg body wt)0.46 ± 0.160.42 ± 0.160
Duration of diabetes (years)7.3 ± 0.910.9 ± 2.60
Years on insulin3.3 ± 1.25.1 ± 2.00
  • Data are means ± SE.